STAGE I CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for STAGE I CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new STAGE I CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for STAGE I CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to rev up immune system against blood cancer
Disease control OngoingThis study tests whether the drug lenalidomide, combined with a vaccine, can help the immune system fight early-stage chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in people with high-risk genetic features. Lenalidomide works by cutting off blood supply t…
Matched conditions: STAGE I CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
Smarter CMV strategy may protect stem cell transplant patients
Disease control OngoingThis study tested a modified approach to prevent and treat cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV therapy could still keep patients safe while reducing unnecessar…
Matched conditions: STAGE I CHRONIC LYMPHOCYTIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New hope for seniors with CLL: major study tests best drug combo
Disease control OngoingThis study is for people aged 65 and older with untreated chronic lymphocytic leukemia (CLL). It compares three treatment options: a standard chemo-immunotherapy (bendamustine plus rituximab), a targeted drug plus immunotherapy (ibrutinib plus rituximab), or the targeted drug alo…
Matched conditions: STAGE I CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:57 UTC